Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Interest & Investment Income (2016 - 2022)

Edesa Biotech's Interest & Investment Income history spans 10 years, with the latest figure at $36137.0 for Q3 2022.

  • For Q3 2022, Interest & Investment Income rose 424.79% year-over-year to $36137.0; the TTM value through Sep 2022 reached $63523.0, up 468.95%, while the annual FY2025 figure was $2558.0, 98.33% down from the prior year.
  • Interest & Investment Income for Q3 2022 was $36137.0 at Edesa Biotech, up from $17518.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $36137.0 in Q3 2022 and bottomed at $747.0 in Q1 2021.
  • The 5-year median for Interest & Investment Income is $10870.0 (2018), against an average of $11655.7.
  • The largest YoY upside for Interest & Investment Income was 577.76% in 2021 against a maximum downside of 96.02% in 2021.
  • A 5-year view of Interest & Investment Income shows it stood at $16211.0 in 2018, then decreased by 12.45% to $14192.0 in 2019, then crashed by 93.5% to $922.0 in 2020, then soared by 563.77% to $6120.0 in 2021, then soared by 490.47% to $36137.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Interest & Investment Income are $36137.0 (Q3 2022), $17518.0 (Q2 2022), and $3748.0 (Q1 2022).